Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland-Using spontaneous resolvers as the benchmark comparator-Reference-Cited by-同舟云学术

Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland-Using spontaneous resolvers as the benchmark comparator

Published:2016-03-19 Issue:5 Volume:63 Page:1506-1516
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Innes Hamish¹²,Hutchinson Sharon J.¹²,Obel Niels³,Christensen Peer B.⁴,Aspinall Esther J.¹²,Goldberg David¹²,Krarup Henrik⁵,McDonald Scott A.¹²,McLeod Allan²,Weir Amanda⁶,Omland Lars H.³

Affiliation:

1. School of Health and Life Sciences; Glasgow Caledonian University; Glasgow UK

2. Health Protection Scotland; Blood borne viruses and STIs; Glasgow UK

3. Department of Infectious Diseases; Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark

4. Department of Infectious Diseases; Odense University Hospital; Odense Denmark

5. Section of Molecular Diagnostics; Clinical Biochemistry, Aalborg University Hospital, Aalborg Hospital; Aalborg Denmark

6. NHS; National Services Scotland; Edinburgh UK

Funder

Scottish government

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.28458/fullpdf

Reference53 articles.

1. A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland;McDonald;Stat Methods Med Res,2009

2. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study;Amin;Lancet,2006

3. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population;El-Kamary;Clin Infect Dis,2011

4. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study;Duberg;J Viral Hepat,2008

5. Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment;Aspinall;J Hepatol,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results from a retrospective case finding and re-engagement exercise for people previously diagnosed with hepatitis C virus to increase uptake of directly acting antiviral treatment;BMC Public Health;2024-09-06

2. Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study;BMJ;2023-08-02

3. Management of Hepatitis C Viral Infection in People Who Inject Drugs;Hepatitis C: Care and Treatment;2021

4. Data linkage to monitor hepatitis C‐associated end‐stage liver disease and hepatocellular carcinoma inpatient stays in England;Journal of Viral Hepatitis;2019-10-03

5. Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol);BMJ Open;2019-09